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Background: It is well known that Swedish men have lower tobacco-related mortality than men in other European
countries, but there are questions that need further investigation to what extent this is related to the specific
patterns of tobacco use in Sweden, where use of snus, the Swedish low-nitrosamine oral tobacco, dominates
over smoking in men but not in women. The recent WHO Global Report: Mortality Attributable to Tobacco provides
a unique set of estimates of the health burden of tobacco in all countries of the world in the year 2004, and these
data can help elucidating the above-mentioned questions.
Methods: For Sweden and all other European Union Member States mortality data for a number of tobacco-related
causes of death were extracted from the WHO Report. The size of the mortality advantage for selected causes
of death in different age groups of Swedish men compared to men of the same age in Europe as a whole was
calculated in terms of ratios of death rates attributable to tobacco. Differences between age groups with respect to
tobacco-related mortality were analyzed with respect to differences in terms of development and status of smoking and
snus use. The analyses also paid attention to differences between countries regarding tobacco control regulations.
Findings: Among men in the European Union Member States the lowest level of mortality attributable to tobacco was
consistently found in Sweden, while Swedish women showed levels similar to European average. A strong co-variation
was found between the mortality advantage and the degree of dominance of snus use in the different age groups of
Swedish men. Among Swedish women there are no age groups with dominant use of snus, and similar observations
were therefore not possible for women.
Conclusion: The above findings support the assumption that the widespread use of snus instead of cigarettes among
Swedish men may be a major part of the explanation behind their position with Europe’s lowest mortality attributable to
tobacco.
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A large study of tobacco use in European Union Member
States around 2002 found that the proportion of daily users
of tobacco among adult men in Sweden was about the
same as the average among men in the EU as a whole [1].
But, Swedish men are unique in their choice of tobacco
products. Most of them use use snus, the Swedish kind of
low-nitrosamine moist snuff, while cigarette smokers are a* Correspondence: lars.ramstrom@tobaccostudies.com
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article, unless otherwise stated.minority. This means that the prevalence of daily smoking
in men is lower in Sweden than in other EU countries.
The WHO Global Report: Mortality Attributable to
Tobacco has provided a unique set of estimates of the
health burden of tobacco in all countries of the world in
the year 2004 [2]. Death rates are reported for the main
tobacco-related diseases and for “All causes”. In this re-
port we find not only observed overall death rates for
various causes of death but also estimates of the Popula-
tion Attributable Fraction (PAF) for tobacco exposure,
i.e. the part of the death rate that is specifically attribut-
able to tobacco. Calculation of PAF can make use of dataed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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often absent and/or lack comparability between coun-
tries. WHO has therefore adapted a method, the PAF/
SIR method (SIR: Smoking Impact Ratio), that instead of
prevalence data makes use of the number of lung cancer
deaths by age and sex. (Technical details are described
in the report). The use of the PAF/SIR method will
therefore have contributed to best possible validity of
the data.
The estimated death rates attributable to tobacco do
directly represent the size of each country’s health bur-
den of tobacco with respect to different diseases and
“All causes”. Estimates are given for men and women in
different age groups and for the total population. The
data for total population are not age standardized, so
they cannot be used for fully representative comparisons
between countries, but such comparisons can be made
for specific age groups.
The purpose of the current study is to describe
differences between Sweden and Europe as a whole with
regard to mortality attributable to tobacco and to investi-
gate how such differences are associated with national char-
acteristics of tobacco use and tobacco control practices.
Methods
An overview of the mortality attributable to tobacco in
different EU Member States was established by extract-
ing from the WHO Report data for each EU country
regarding death rates attributable to tobacco for se-
lected causes of death in men and women. To get com-
parability between countries, data for a specific age
group, 60-69, were used. To illustrate the wide inter-
country differences, data were presented for Sweden
and for minimum, median and maximum countries
outside Sweden, see Table 1.
In order to get more detailed comparisons for some of




Lung cancer 87 91
Other cancer 36 41
All cardiovascular 72 107
All causes 222 378
WOMEN
Lung cancer 61 5
Other cancer 17 1
All cardiovascular 63 5
All causes 173 14
Men and women age 60-69.groups, ratios between death rates attributable to to-
bacco in Sweden and corresponding rates for Europe as
a whole, see Table 2. This analysis includes men only,
since Swedish women, as seen in Table 1, do not differ
from EU average so as Swedish men do.
In order to account for major differences between age
groups with regard to patterns of tobacco use data were
retrieved from studies published by Statistics Sweden [3].
The data in Table 3 show how prevalence of smoking
and snus use changed in different age groups up to the
time represented by the WHO report. Here again the
analysis includes men only.
Other potential determinants of tobacco use in differ-
ent countries consist of market regulations and other
kinds of tobacco control legislation. The analyses in the
current study do therefore also take into account the
differences between European countries with respect
to tobacco control regulations. These matters are
described in The Tobacco Control Scale 2010 in Europe, a
report published by the Association of European Cancer
Leagues [4].
Findings
Differences between countries in Europe
The Tobacco Control Scale 2010 in Europe presents an
assessment of the implementation of selected national
tobacco control policies in 30 European countries. Six
policy areas were taken into account: pricing, smoking
restrictions, public information, advertising bans, warn-
ing labels and treatment opportunities. The top ranking
country got 77 points out of 100 possible, the lowest
ranking country got 32. Sweden scored quite modestly
and got just 51 points.
The WHO Report shows large differences between
European Union Member States with regard to death
rates specifically attributable to tobacco. For example,














All causes Lung cancer All cardiovascular
45-59 0.15 0.24 0.13
60-69 0.27 0.38 0.19
70-79 0.42 0.49 0.33
Men in Sweden vs. men in Europe as a whole 2004.
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shows, for the age group 60–69, some more compari-
sons between Sweden and the other European Union
Member States. Among Swedish men the death rates at-
tributable to tobacco are lower than among men in any
other EU country, while Swedish women have rates
similar to the European average.
Sweden/Europe mortality comparisons by age groups
Table 2 shows, for different age groups, ratios between
death rates attributable to tobacco for men in Sweden vs
men in Europe as a whole. For each cause of death these
ratios demonstrate substantially lower mortality attribut-
able to tobacco for men in Sweden than for men of same
age in Europe as a whole. The differences between
Sweden and Europe as a whole are considerably larger
in younger age groups than in older ones.
Tobacco use changes among Swedish men in different
age groups
The death rates attributable to tobacco that are pre-
sented in the WHO report are determined by the devel-
opment of the tobacco use up to the year 2004. The data
in Table 3 show that in all age groups the prevalence of
smoking was going down, and the prevalence of snus
use was going up. Thereby snus use became an increas-
ing proportion of the total tobacco use. Further, the shift
from cigarettes to snus was substantially more pro-
nounced in younger than in older age groups.
Discussion
The WHO Report data on mortality attributable to to-
bacco demonstrate that Swedish men stand out in a
uniquely favourable position in comparison with other
European Union Member States. What can explain this




Daily smoking Daily snus use
1988/89 2004/05 1988/89 2004/05
35-44 33% 13% 19% 31%
45-54 32% 21% 11% 24%
55-64 28% 21% 9% 18%The position of a country in a comparison of death
rates attributable to tobacco is influenced by various na-
tional conditions with regard to political action and per-
sonal practices. Sweden’s modest scoring on The
Tobacco Control Scale 2010 in Europe suggests that the
kinds of national political action measured by that survey
can not explain the uniquely low level of tobacco-related
mortality for Swedish men. The main explanation must ra-
ther come from some Swedish-men-specific factor that was
not taken into account in the above assessment. One such
factor is the use by Swedish men of the Swedish low-
toxicity oral tobacco, snus, instead of cigarettes. During the
last 50 years the initially high smoking rates in men have
been drastically reduced, and snus use has become the
dominating kind of tobacco use among men, while female
use of snus is still on a low level [5].
The age-group-specific mortality ratios Sweden vs Eur-
ope as a whole add further details regarding the relative
position of Swedish men. The observation that younger
age groups exhibit even more favourable positions than
older ones, raises the question how differences between
age groups with respect to development and levels of
smoking and snus use play a role for the differences with
respect to the ratios of death rates. This question can be
elucidated by mortality data from the data base NORD-
CAN [6]. For example, data from this source show that
age-specific lung cancer death rates for men in Sweden
were decreasing from 1989 to 2005 by 46% in the age
group 35–44, by 28% in the age group 45-54 and by 15% in
the age group 55–64. This confirms the observation from
Table 2 that the mortality advantage was largest in the age
groups with largest dominance of snus use over smoking.
This co-variation between mortality advantage and snus
dominance suggests that the use of snus instead of smoking
can be an important part of the explanation why younger
age groups stand out even more favourably than older ones
in the comparison with Europe as a whole.
Conclusion
The low toxicity of Swedish snus is well recognized
[7-9]. Consequently, there is general agreement that use of
snus instead of cigarettes will be beneficial for the health of
individual users. At the same time questions have been
raised about the effects on population level. However, sci-
entific studies in Sweden have found that snus use among
men has contributed both to less initiation of smoking and
to more cessation of smoking [10-13]. These findings in
combination with the low toxicity suggest a potential for
significant public health benefits [14]. The above analysis of
data from the new WHO report and Swedish sources sup-
ports the assumption that the use of snus among Swedish
men has yielded substantial public health benefits by con-
tributing to make their level of mortality attributable to
tobacco lowest in Europe.
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